Pfizer (PFE) PT Raised to $70 at Cowen as Vaccine and Paxlovid Could Add $50B in Sales Next Year
Tweet Send to a Friend
Cowen analyst Steve Scala raised the price target on Pfizer (NYSE: PFE) to $70.00 (from $56.00) while maintaining an Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
